Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;12(5):e70008.
doi: 10.1002/prp2.70008.

An improvement of the safety profile of SARS-CoV-2 vaccines is desirable

Affiliations

An improvement of the safety profile of SARS-CoV-2 vaccines is desirable

Josef Finsterer. Pharmacol Res Perspect. 2024 Oct.
No abstract available

Keywords: Guillain‐Barre syndrome; SARS‐CoV‐2 vaccination; VITT; adverse reactions; side effects.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

References

    1. Padilla‐Flores T, Sampieri A, Vaca L. Incidence and management of the main serious adverse events reported after COVID‐19 vaccination. Pharmacol Res Perspect. 2024;12(3):e1224. doi:10.1002/prp2.1224 - DOI - PMC - PubMed
    1. Scholkmann F, May CA. COVID‐19, post‐acute COVID‐19 syndrome (PACS, "long COVID") and post‐COVID‐19 vaccination syndrome (PCVS, "post‐COVIDvac‐syndrome"): similarities and differences. Pathol Res Pract. 2023;246:154497. doi:10.1016/j.prp.2023.154497 - DOI - PMC - PubMed
    1. Abara WE, Gee J, Marquez P, et al. Reports of Guillain‐Barré syndrome after COVID‐19 vaccination in the United States. JAMA Netw Open. 2023;6(2):e2253845. doi:10.1001/jamanetworkopen.2022.53845 - DOI - PMC - PubMed
    1. Algahtani HA, Shirah BH, Albeladi YK, Albeladi RK. Guillain‐Barré syndrome following the BNT162b2 mRNA COVID‐19 vaccine. Acta Neurol Taiwanica. 2023;32(2):82‐85. - PubMed

Substances

LinkOut - more resources